People with long-term conditions, such as diabetes or heart disease, are two to three times more likely to experience mental health problems than the general population. However, a systemic failure to identify these problems and provide effective support is resulting in poorer outcomes for patients and could be costing the NHS billions, says a report [read the full story…]
This new systematic review compares how effective first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) are at preventing relapse in patients with schizophrenia. The authors carried out a meta-analysis of 23 randomised controlled trials that lasted for ≥6 months and compared FGAs with SGAs in schizophrenia. The outcomes they studied were: Study defined relapse Relapse at 3, [read the full story…]
The Joint Commissioning Panel for Mental Health (JCP-MH) have published the first of their guides aimed at GPs who will soon be commissioning mental health services. Each of the guides provide a description of what a ‘good’ service configuration should look like, and brings together scientific evidence, service user and carer experience, and case studies [read the full story…]
A multidisciplinary group of Dutch scientists have produced a guideline to help diagnose and treat medically unexplained physical symptoms (MUPS) and somatoform disorders (SD) in primary care, hospitals and occupational health settings. The guideline summarises the best available evidence and attempts to answer 4 key questions, for which the following findings are presented: 1. Preventive [read the full story…]
The NHS Commissioning Board has published a series of resources which may be useful for emerging clinical commissioning groups (CCGs). They include guidance and process documents, toolkits and other information around authorisation, governance, establishment and commissioning support. Developing Clinical Commissioning Groups: Towards authorisation (PDF) was published back in September 2011. It is now accompanied by Towards establishment: [read the full story…]
In 2004 the US Food and Drug Administration published a “black box” warning that highlighted an increased risk of suicide and suicidal thoughts in young people who were taking antidepressants. This warning was updated in 2007. A new analysis of 41 randomised controlled trials has been published in the Archives of General Psychiatry, which suggests [read the full story…]
We have learnt so much about mental illness in the last few decades and the science behind diagnosing, managing and supporting people with individual conditions has improved dramatically. Despite this improved knowledge, public attitudes to mental health issues remain varied and we still frequently hear horror stories about how people with mental health conditions are [read the full story…]
Every year in England and Wales, a suicide occurs in roughly one patient for every thousand in mental health treatment. These numbers make it hard to research what mental health service providers can do to prevent further suicides, so it’s encouraging to see a new cross-sectional observational study published in the Lancet with funding from [read the full story…]
There’s an interesting review in the British Journal of Psychiatry this week, which compares the effectiveness of psychiatric drugs with those used to treat physical health problems. The headline from the review is that ‘psychiatric drugs are as effective as other drugs’. Professor Stefan Leucht who led the review team claims that: There is a [read the full story…]
In April 2013, subject to the Health and Social Care Bill becoming law, local authorities will become responsible for commissioning drug treatment and recovery services. An effective approach to tackling substance misuse will require partnership working across local authorities, health bodies and criminal justice agencies. The object is not only for individuals to overcome dependency, [read the full story…]
